attenu
salmonella
enterica
serovar
typhi
strain
consid
attract
potenti
live
oral
deliveri
vector
vaccin
abil
elicit
full
array
immun
respons
human
studi
construct
attenu
enterica
serovar
typhi
strain
stabli
express
conserv
nucleocapsid
n
protein
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
integr
n
gene
pilv
gene
control
type
ivb
pilu
operon
promot
enterica
serovar
typhi
balbc
mice
immun
recombin
strain
differ
rout
intranas
orogastr
intraperiton
intraven
result
show
intranas
rout
caus
highest
product
specif
immunoglobulin
g
igg
secretori
iga
imprint
cell
bia
moreov
recombin
live
vaccin
induc
significantli
high
level
specif
cytotox
tlymphocyt
activ
increas
gamma
interferonproduc
cell
compar
parent
strain
work
provid
insight
type
ivb
pilu
operon
promot
control
sarscov
n
gene
express
salmonella
might
attract
livevector
vaccin
srascov
infect
could
induc
mucos
humor
cellular
immun
respons
work
also
indic
type
ivb
pilu
operon
promot
control
foreign
gene
express
salmonella
elicit
full
immun
respons
intranas
vaccin
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
new
emerg
viru
high
mortal
rate
along
huge
econom
impact
worldwid
contain
five
major
open
read
frame
encod
replicas
polyprotein
spike
protein
envelop
e
protein
membran
glycoprotein
nucleocapsid
n
protein
n
protein
sarscov
conserv
protein
particip
replic
transcript
viru
interfer
cell
cycl
host
cell
amino
acid
sequenc
homolog
sarscov
cov
low
possibl
caus
differ
pathogenesi
report
sar
patient
posit
n
proteinspecif
antibodi
appear
earli
stage
infect
studi
show
highest
immun
respons
gener
dna
vaccin
n
gene
sarscov
mice
among
construct
encod
n
e
protein
therefor
n
protein
chosen
target
antigen
studi
current
vaccin
licens
human
sarscov
although
effect
vaccin
develop
anim
cov
recent
sever
vaccin
strategi
examin
prevent
sar
infect
includ
inactiv
virus
dna
vaccin
recombin
viral
vector
base
adenovirus
baculovirus
parainfluenza
virus
addit
surfacedisplay
sarscov
spike
protein
lactobacillu
casei
report
induc
neutral
antibodi
mice
studi
anim
cov
vaccin
demonstr
system
cellmedi
immun
respons
import
prevent
viral
infect
dna
vaccin
target
n
protein
sarscov
gener
strong
nspecif
humor
cellular
immun
reduc
titer
challeng
vaccinia
viru
express
n
protein
sar
viru
sarscov
n
protein
protein
could
induc
long
persist
memori
tcell
respons
human
piec
evid
indic
humor
cellular
immun
respons
vital
defens
acut
sar
infect
initi
sarscov
infect
occur
primarili
mucos
epitheli
cell
respiratori
tract
evid
mucos
immun
import
rapid
immun
respons
mucos
infect
thu
order
develop
effect
vaccin
sarscov
good
sar
vaccin
candid
elicit
mucos
system
immun
attenu
salmonella
strain
suppos
attract
potenti
live
oral
deliveri
vector
vaccin
abil
elicit
full
array
immun
respons
human
previous
demonstr
salmonella
enterica
serovar
typhi
pil
km
r
mutant
strain
significantli
attenu
adhes
invas
human
intestin
monocyt
cell
compar
wildtyp
strain
type
ivb
pil
operon
enterica
serovar
typhi
contain
gene
pillmnopqrstuv
pil
encod
main
structur
protein
pilv
code
pilustip
adhes
type
ivb
pili
gene
form
transcript
unit
control
one
pil
promot
evidenc
absenc
independ
promot
studi
sought
obtain
effect
salmonellabas
viral
vaccin
candid
mucos
system
immun
construct
enterica
serovar
typhi
pil
km
r
pilv
n
mutant
strain
integr
n
gene
pilv
gene
control
pil
operon
promot
first
step
toward
construct
live
oral
salmonellasarscov
vaccin
analyz
specif
immun
respons
mice
differ
immun
rout
strain
plasmid
attenu
enterica
serovar
typhi
strain
cy
tri
via
rif
r
pil
kan
r
sourc
vaccin
strain
studi
eukaryot
express
vector
express
fulllength
n
gene
sarscov
strain
whu
describ
previous
construct
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
vaccin
stabli
express
n
protein
sarscov
import
approach
use
construct
recombin
vaccin
homolog
recombin
plasmid
contain
apaiecorv
digest
site
fragment
pilv
rci
gene
cleav
bamhi
gener
small
fragment
larg
fragment
larg
fragment
relig
gener
new
plasmid
name
n
gene
kb
sarscov
obtain
digest
bamhi
ecori
insert
vector
digest
bglii
ecori
creat
recombin
plasmid
plasmid
transfer
enterica
serovar
typhi
pil
km
r
strain
via
enterica
serovar
typhimuriummodifi
strain
r
ap
r
km
r
select
individu
clone
grown
ml
lb
medium
without
antibiot
select
period
ca
h
transfer
aliquot
ml
fresh
medium
three
four
transfer
aliquot
plate
onto
lb
medium
contain
kanamycin
result
coloni
lost
transform
plasmid
check
ampicillin
sensit
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
vaccin
n
gene
insert
enterica
serovar
typhi
genom
screen
larg
number
coloni
examin
pcr
amplif
use
primer
adjac
insid
insert
fragment
well
western
blot
analysi
pcr
use
identifi
n
gene
enterica
serovar
typhi
pil
km
r
pilv
n
strain
primer
outsid
recombin
sequenc
use
amplif
primer
insert
sequenc
use
amplif
express
n
protein
enterica
serovar
typhi
pil
km
r
pilv
n
strain
determin
western
blot
analysi
immun
process
optim
sevento
femal
balbc
mice
prepar
immun
four
group
six
mice
per
group
mice
immun
recombin
strain
parent
bacterium
strain
intrans
dispens
l
vaccin
suspens
contain
cfu
directli
mous
nasal
caviti
ii
orogastr
og
place
l
vaccin
suspens
contain
cfu
lower
esophagu
use
gavag
needl
iii
intraperiton
ip
iv
intraven
iv
inject
l
vaccin
suspens
contain
cfu
abdomin
caviti
vena
caudali
respect
day
mice
euthan
day
last
immun
product
serum
immunoglobulin
g
igg
n
protein
measur
enzymelink
immunosorb
assay
elisa
purif
recombin
n
protein
antibodi
product
n
gene
sarscov
gener
digest
bamhi
ecori
clone
bamhi
ecori
site
prokaryot
vector
pgexkg
yield
plasmid
pgexn
plasmid
pgexn
transform
e
coli
plyss
glutathion
stransferas
gst
n
fusion
protein
overexpress
e
coli
induct
iptg
express
protein
purifi
glutathion
sepharos
amersham
bioscienc
antin
antibodi
prepar
immun
rabbit
sera
recombin
gstn
protein
measur
antibodi
level
elisa
antin
antibodi
detect
week
final
immun
level
antibodi
n
protein
determin
elisa
briefli
plate
coat
l
recombin
n
protein
gml
express
purifi
e
coli
carbon
buffer
ph
h
block
overnight
bovin
serum
albumin
incub
plate
wash
phosphatebuff
salin
pb
contain
tween
pbst
sera
subject
titer
determin
twofold
serial
dilut
antibodi
bound
immobil
antigen
detect
use
horseradish
peroxidaselabel
antimous
immunoglobulin
g
igg
southern
biotech
dilut
ratio
pbst
substrat
solut
contain
ophenylenediamin
mg
ml
h
citrat
phosphat
buffer
test
control
sera
run
triplic
detect
antin
secretori
iga
siga
briefli
flatbottom
microtit
plate
coat
recombin
n
protein
express
purifi
e
coli
block
bovin
serum
albumin
supernat
extract
g
origin
fecal
pellet
mous
mix
l
pb
subject
titer
determin
twofold
serial
dilut
sampl
incub
lwell
h
horseradish
peroxidaseconjug
goat
antimous
iga
antibodi
southern
biotech
ad
dilut
pbst
incub
h
experiment
control
sampl
run
triplic
stabl
transfect
total
murin
colon
tumor
cell
place
plate
h
transfect
plate
cell
transfect
g
plasmid
lipofectamin
invitrogen
stabl
transfect
ad
cell
cultur
medium
final
concentr
mgml
h
posttransfect
cell
cultur
medium
chang
everi
day
week
select
nexpress
cell
obtain
cell
well
contain
singl
clone
select
analysi
individu
transfect
clone
test
express
n
protein
western
blot
analysi
specif
ctl
activ
sevento
femal
balbc
mice
immun
l
recombin
strain
parent
bacterium
strain
day
respect
mice
euthan
day
splenocyt
mice
resuspend
complet
rpmi
fetal
bovin
serum
analyz
cytotox
tlymphocyt
ctl
activ
twofold
serial
dilut
mice
splenocyt
expand
effector
cell
cellswel
stimul
recombin
n
protein
gml
express
purifi
e
coli
vitro
incub
major
histocompat
complex
mhc
match
stabli
express
n
protein
target
cell
cellswel
h
presenc
co
cultur
centrifug
rpm
min
l
supernat
per
well
transfer
enzymat
assay
plate
lysi
determin
measur
releas
lactat
dehydrogenas
ldh
use
cytotox
assay
kit
promega
corp
madison
wi
absorb
valu
supernat
record
nm
elisa
micropl
reader
data
mean
standard
deviat
sd
five
differ
well
percentag
cytotox
calcul
experiment
effector
spontan
target
spontan
target
maximum
target
spontan
spontan
releas
count
releas
target
cell
absenc
effect
cell
maxim
releas
number
count
releas
presenc
lysi
solut
elispot
assay
enzymelink
immunospot
elispot
assay
filtrat
plate
coat
overnight
l
gml
antimous
gamma
interferon
steril
pb
plate
block
h
rpmi
contain
fetal
calf
serum
bovin
serum
albumin
wash
three
time
steril
pb
variou
dilut
splenocyt
immun
control
mice
l
complet
medium
place
well
cultur
h
rpmi
alon
neg
control
g
per
ml
recombin
n
protein
express
purifi
e
coli
g
per
ml
concanavalin
vol
salmonellabas
sarscov
nucleocapsid
vaccin
statist
analysi
oneway
analysi
varianc
anova
student
test
use
comparison
antibodi
titer
cytotox
level
tumor
growth
product
elispot
among
differ
group
test
perform
use
spss
softwar
valu
p
consid
signific
fig
vaccin
strain
confirm
pcr
amplif
use
primer
outsid
recombin
sequenc
n
gene
insert
pilv
gene
fig
size
pcr
product
bp
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
vaccin
strain
fig
pcr
product
enterica
serovar
typhi
pil
km
r
parent
strain
bp
fig
pcr
use
primer
insert
sequenc
fig
also
indic
n
gene
bp
insert
pilv
gene
genom
dna
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
strain
examin
n
protein
express
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
strain
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
western
blot
analysi
shown
fig
protein
band
approxim
kda
correspond
molecular
mass
n
protein
cell
lysat
enterica
serovar
typhi
pil
km
r
pilv
n
strain
fig
lane
identifi
detect
cell
lysat
enterica
serovar
typhi
pil
km
r
parent
strain
fig
lane
result
demonstr
n
protein
sarscov
express
newli
construct
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
strain
demonstr
stabil
insert
express
vaccin
strain
sever
vitro
passag
enterica
serovar
typhi
pil
km
r
pilv
n
vaccin
strain
elicit
predomin
subclass
antibodi
respons
serum
igg
respons
n
protein
determin
balbc
mice
immun
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
vaccin
strain
differ
immun
rout
includ
og
ip
iv
result
elisa
analysi
show
immun
rout
caus
highest
level
antin
proteinspecif
igg
fig
b
versu
og
ip
iv
p
addit
og
immun
rout
induc
highest
level
specif
siga
among
rout
march
guest
http
cviasmorg
fig
parent
strain
insert
nonimmun
mice
control
induc
detect
antibodi
respons
data
suggest
immun
best
rout
recombin
vaccin
therefor
chose
immun
rout
rest
experi
studi
mice
presenc
antibodi
indic
respons
sinc
cytokin
necessari
isotyp
shift
b
cell
result
demonstr
immun
mice
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
strain
could
induc
respons
parent
strain
addit
recombin
strain
could
elicit
specif
mucos
immun
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
vaccin
stimul
specif
ctl
respons
mice
mice
immun
recombin
strain
parent
bacterium
strain
day
respect
euthan
day
specif
ctl
activ
splenocyt
immun
mice
examin
splenocyt
immun
mice
restimul
recombin
n
protein
vitro
expand
effector
cell
incub
mhcmatch
cell
stabli
express
n
protein
target
cell
ctl
assay
show
recombin
vaccin
strain
elicit
significantli
higher
level
specif
ctl
respons
enterica
serovar
typhi
pil
km
r
parent
strain
control
group
fig
determin
highest
ctl
activ
detect
ratio
effector
cell
target
cell
e
result
demonstr
secret
indic
respons
product
indic
respons
use
elispot
techniqu
product
detect
splenocyt
immun
mous
group
stimul
recombin
n
protein
express
purifi
e
coli
splenocyt
recombin
strain
group
induc
significantli
higher
level
cell
mean
sd
parent
strain
group
mean
sd
p
fig
howev
signific
differ
level
express
cell
among
group
includ
recombin
vaccin
group
parent
strain
group
nonimmun
control
group
fig
indic
recombin
strain
induc
immun
respons
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
vaccin
inhibit
nexpress
tumor
grow
vivo
specif
cellular
immun
respons
crucial
mechan
defens
intracellular
microorgan
virus
tumor
studi
balbc
mice
immun
recombin
vaccin
parent
strain
day
last
immun
mice
given
subcutan
inject
target
cell
stabli
express
n
protein
cell
balbc
mice
recogn
mhcimatch
cell
protect
balbc
mice
tumor
challeng
result
show
tumor
size
recombin
vaccin
group
significantli
smaller
control
parent
strain
group
p
fig
b
size
tumor
increas
significantli
timedepend
fashion
parent
strain
group
insignificantli
recombin
vaccin
group
fig
data
show
recombin
strain
could
inhibit
nexpress
tumor
grow
vivo
increas
specif
cellular
immun
respons
enterica
serovar
typhi
strain
attract
use
vaccin
vector
sinc
administ
natur
rout
infect
ie
oral
capabl
elicit
system
mucos
immun
respons
close
relat
salmonella
serovar
recogn
enterica
serovar
typhi
one
invad
bloodstream
caus
system
infect
immun
exclus
human
attenu
enterica
serovar
typhi
strain
exampl
enterica
serovar
typhi
report
use
express
heterolog
antigen
protein
deliv
immun
system
human
studi
possibl
use
enterica
serovar
typhi
live
vector
express
heterolog
antigen
deliv
genet
form
multival
vaccin
could
protect
sever
divers
pathogen
attract
altern
vaccin
develop
deliveri
studi
reason
select
enterica
serovar
typhi
pil
km
r
strain
parent
bacterium
express
virul
antigen
vi
express
type
ivb
pili
defect
type
ivb
pilu
pathogen
identifi
import
virul
factor
requir
pathogen
moreov
type
ivb
pilu
operon
confin
enterica
serovar
typhi
humaninvas
strain
salmonella
enterica
serovar
paratyphi
c
dublin
enterica
serovar
typhi
mutant
pil
km
r
strain
significantli
attenu
adhes
invas
human
intestin
monocyt
cell
compar
wildtyp
strain
attenu
enterica
serovar
typhi
strain
exampl
enterica
serovar
typhi
immunogen
remark
particularli
vaccin
administ
capsul
form
oral
vaccin
highli
immunogen
enterica
serovar
typhi
deriv
made
test
date
either
caus
fever
may
retain
potenti
caus
fever
least
small
number
volunt
recipi
attenu
enterica
serovar
typhi
pil
km
r
strain
ex
march
guest
http
cviasmorg
amin
studi
possibl
elicit
full
strong
immun
respons
natur
rout
infect
result
clearli
show
type
ivb
pilu
operon
promot
control
nucleocapsid
gene
express
sarscov
enterica
serovar
typhi
pil
km
r
pilv
n
strain
could
elicit
full
specif
immun
respons
vaccin
sinc
plasmid
dna
rel
easili
lost
construct
attenu
enterica
serovar
typhi
vaccin
stabli
express
conserv
n
protein
sarscov
integr
n
gene
pilv
gene
control
pil
promot
chromosom
strain
express
n
protein
vaccin
strain
stabl
mani
vitro
passag
data
shown
howev
attenu
enterica
serovar
typhi
strain
deriv
rifampinresist
vineg
mutant
kanamycin
cassett
insert
inact
pil
therefor
strain
encod
resist
two
antibiot
limit
experiment
clinic
studi
done
anim
reason
futur
work
may
perform
insert
candid
antigen
gene
exampl
gene
code
sar
viral
spike
protein
two
antibiot
resist
gene
rif
r
kam
r
confer
resist
recent
year
dose
model
use
demonstr
immunogen
enterica
serovar
typhi
vaccin
strain
number
studi
exampl
enterica
serovar
typhi
cvd
express
major
protein
leishmania
mexicana
mexicana
shown
immunogen
pathway
elicit
humor
cellular
immun
respons
pickett
et
al
report
attenu
enterica
serovar
typhi
livevector
vaccin
strain
highli
immunogen
mice
follow
og
inocul
despit
establish
util
murin
model
littl
known
immunogen
serovar
typhi
vaccin
strain
administ
differ
rout
demonstr
rout
immun
caus
highest
product
specif
igg
siga
sarscov
n
antigen
deliv
enterica
serovar
typhi
livevector
vaccin
compar
og
ip
iv
rout
fig
addit
administr
cfu
bacteria
iv
ip
rout
could
caus
death
mice
data
shown
cfu
bacteria
iv
ip
induc
enough
immunogen
respons
fig
therefor
consid
rout
best
although
dose
og
applic
higher
ip
iv
might
effect
magnitud
respons
safeti
concern
rout
live
bacteri
vector
strain
human
might
consid
investig
cellmedi
immun
respons
crucial
mechan
defens
intracellular
pathogen
tumor
although
remain
elus
new
emerg
sarscov
data
show
recombin
strain
could
inhibit
nexpress
tumor
grow
vivo
fig
stimul
specif
cellular
immun
respons
also
observ
attenu
enterica
serovar
typhi
pil
km
r
pilv
n
vaccin
elicit
strong
specif
ctl
respons
fig
measur
ldh
releas
assay
e
ratio
signific
increas
ctl
respons
e
ratio
data
shown
reason
known
specul
one
reason
might
due
minim
activ
detect
follow
vitro
expans
memori
cell
anoth
possibl
ctl
activ
measur
direct
mhci
perforinmedi
lysi
experi
sever
advantag
attenu
enterica
serovar
typhi
pil
km
r
pilv
n
recombin
vaccin
first
elicit
system
immun
attenu
rel
safe
second
use
mucos
vaccin
vector
deliv
pathogenspecif
protect
epitop
mucosaassoci
lymphoid
tissu
third
easi
manipul
grow
quickli
cost
much
less
viral
vector
vaccin
dna
vector
vaccin
mucos
system
immun
respons
carrier
foreign
antigen
may
obtain
via
rout
effect
live
vaccin
elicit
mucos
system
immun
respons
sarscov
limit
newli
construct
attenu
enterica
serovar
typhi
pil
km
r
pilv
n
vaccin
prove
highli
profici
livevaccin
candid
work
also
provid
insight
integr
foreign
gene
gene
control
type
ivb
pilu
promot
attenu
enterica
serovar
typhi
live
vector
might
attract
vaccin
deliveri
vaccin
candid
develop
intracellular
microorgan
infect
respiratori
infect
inhibit
tumor
growth
due
abil
stabli
express
foreign
antigen
induc
mucos
humor
cellular
immun
respons
